Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS. Lee SH, et al. Among authors: yoon mh. Clin Ther. 2007 Nov;29(11):2365-73. doi: 10.1016/j.clinthera.2007.11.002. Clin Ther. 2007. PMID: 18158077 Clinical Trial.
Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group, 8-week follow-up, noninferiority trial.
Hong SJ, Ahn TH, Baek SH, Cho WH, Jeon HK, Kwan J, Yoon MH, Lee KJ, Lim DS. Hong SJ, et al. Among authors: yoon mh. Clin Ther. 2006 Apr;28(4):537-51. doi: 10.1016/j.clinthera.2006.04.008. Clin Ther. 2006. PMID: 16750465 Clinical Trial.
Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS; Korean Multicenter Amlodipine Study Investigators. Kim SH, et al. Among authors: yoon mh. Clin Ther. 2007 Sep;29(9):1924-36. doi: 10.1016/j.clinthera.2007.09.018. Clin Ther. 2007. PMID: 18035192 Clinical Trial.
Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
Hong BK, Park CG, Kim KS, Yoon MH, Yoon HJ, Yoon JH, Yang JY, Choi YJ, Cho SY. Hong BK, et al. Among authors: yoon jh, yoon hj, yoon mh. Am J Cardiovasc Drugs. 2012 Jun 1;12(3):189-95. doi: 10.2165/11597410-000000000-00000. Am J Cardiovasc Drugs. 2012. PMID: 22462558 Clinical Trial.
Impact of female gender on bleeding complications after transradial coronary intervention (from the Korean Transradial Coronary Intervention registry).
Shin JS, Tahk SJ, Yang HM, Yoon MH, Choi SY, Choi BJ, Lim HS, Lee YH, Seo KW, Park SJ, Choi YW, Yoon J, Youn YJ, Cho BR, Cha KS, Han KR, Hyon MS, Rha SW, Kim BO, Shin WY, Park KS, Cheong SS, Jeong MH. Shin JS, et al. Among authors: yoon j, yoon mh. Am J Cardiol. 2014 Jun 15;113(12):2002-6. doi: 10.1016/j.amjcard.2014.03.042. Epub 2014 Apr 1. Am J Cardiol. 2014. PMID: 24793670
Point-of-care measurements of platelet inhibition after clopidogrel loading in patients with acute coronary syndrome: comparison of generic and branded clopidogrel bisulfate.
Seo KW, Tahk SJ, Yang HM, Yoon MH, Shin JH, Choi SY, Lim HS, Hwang GS, Choi BJ, Park JS, Shin JS, Lee YH, Choi YW, Park SJ, Jin XJ. Seo KW, et al. Among authors: yoon mh. Clin Ther. 2014 Nov 1;36(11):1588-94. doi: 10.1016/j.clinthera.2014.07.018. Epub 2014 Sep 15. Clin Ther. 2014. PMID: 25218311 Clinical Trial.
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.
Kim CJ, Park MW, Kim MC, Choo EH, Hwang BH, Lee KY, Choi YS, Kim HY, Yoo KD, Jeon DS, Shin ES, Jeong YH, Seung KB, Jeong MH, Yim HW, Ahn Y, Chang K; TALOS-AMI investigators. Kim CJ, et al. Lancet. 2021 Oct 9;398(10308):1305-1316. doi: 10.1016/S0140-6736(21)01445-8. Lancet. 2021. PMID: 34627490 Clinical Trial.
Distal protection device protects microvascular integrity during primary percutaneous intervention in acute myocardial infarction: a prospective, randomized, multicenter trial.
Tahk SJ, Choi BJ, Choi SY, Yoon MH, Gwon HC, Hong GR, Kim YJ, Hur SH, Kim KB, Koo BK, Lee SH, Yoon J. Tahk SJ, et al. Among authors: yoon j, yoon mh. Int J Cardiol. 2008 Jan 11;123(2):162-8. doi: 10.1016/j.ijcard.2007.03.124. Epub 2007 May 8. Int J Cardiol. 2008. PMID: 17490759 Clinical Trial.
395 results